New eczema treatment offers hope for devastating skin disease
The FDA has approved a new drug designed to treat moderate to severe cases of eczema that fail to respond to other options, such as topical applications. The price of the medication high, but help is available, offering hope for patients with moderate to severe eczema.
Eczema is a skin condition that has a major impact on a person's quality of life, depending on the severity. Some people shun social interaction because of the itchy, scaly patches that occur from the condition.
"Moderate-to-severe atopic dermatitis is a debilitating, life-altering disease with very limited treatment options. Many patients suffer for years with widespread inflamed skin, intense itch, sleep disturbances and other challenges," said Julie Block, Chief Executive Officer, National Eczema Association in a media release.
Dupixent Eczema Treatment
The medication, Dupixent (dupilumab) that can easily be self-injected every other week from a pre-loaded syringe is poised to help the pharmaceutical company, with a predicted $3 billion in annual sales, according to analysts.
The drug is shown in clinical trials to help those with the condition that can be devastating and until now, treatment options have been sparse.
The cost of the medication is $37,000 a year, which is lower than some biologics that treat autoimmune diseases.
Drug pricing has come under scrutiny recently as President Trump has vowed to put an end to high drugs costs. Regeneron has taken an added step to negotiate prices ahead of time with insurers and they are also helping patients get the medication.
Where to go for eczema treatment help
The good news is if you suffer from eczema and your doctor recommends the medication, you may be able to get the drug through coupons or rebates, according to the maufacturer, Sanofi and Regeneron.
A contraindication for the eczema drug includes a history of asthma.
For those with no insurance or who need assistance with the medication, Dupixent MyWayTM can offer assistance, including support from registered nurses and other specialists, 24 hours a day. You can also call 1-844-Dupixent (1-844-387-4936) or visit www.Dupixent.com.
Eczema is an incurable skin condition that often affects children and lasts a lifetime. The injection, though the price is high, is attainable and offers hope for an estimated 300,000 people in the U.S. battling moderate to severe cases of the skin disease whose treatment options are limited or ineffective.
More reading on Eczema Treatment